Thursday, July 3, 2025 7/3/2025

Defining the mechanism of lipid peroxidation in controlling Staphylococcus aureus infections

Award Number: K22AI153677
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 09/12/2022
PERIOD OF PERFORMANCE END DATE: 08/31/2024

Group Awards By:

View Award Description

Defining the mechanism of lipid peroxidation in controlling Staphylococcus aureus infections - Project Summary Staphylococcus aureus infects every niche of the human host and is the leading cause of Gram-positive sepsis. There are over 900,000 severe S. aureus infections in the United States annually, emphasizing the need for new antibiotics to treat these infections. Understanding the molecular mechanisms used by the host to kill S. aureus and by S. aureus to defend against host killing will identify and validate novel targets for antimicrobial design. When the host encounters S. aureus, immune cells excrete various bactericidal small molecules. One class of bactericidal small molecules are polyunsaturated fatty acids, which are toxic to many bacterial species, but until recently the mechanism of toxicity was undefined. We discovered that arachidonic acid (AA), an abundant host polyunsaturated fatty acid, is bactericidal against S. aureus through a lipid peroxidation mechanism. AA is oxidized in S. aureus to a,b-unsaturated carbonyls and g-ketoaldehydes that are electrophilic, reacting with nucleophilic amino acids of the S. aureus proteome. Scavenging either oxidants that initiate lipid peroxidation or electrophiles generated through lipid peroxidation protects S. aureus from AA killing, confirming lipid peroxidation generated electrophiles as the bactericidal effectors of AA. Discovering the mechanism of AA toxicity against S. aureus is just the first step in identifying and validating lipid peroxidation as an antimicrobial strategy. We do not know the lipid electrophile species generated in S. aureus and what S. aureus proteins are targeted by electrophiles. We also do not know the S. aureus processes that produce the oxidants responsible for initiating lipid peroxidation or the identity of the oxidants produced in S. aureus. Finally, we do not know the specific host niches where lipid peroxidation is bactericidal or which host niches are most promising to test lipid peroxidation as an antimicrobial therapy. This proposal will expand the understanding of the bactericidal mechanisms of AA both in vitro and in vivo by testing three main hypotheses. In Aim 1, we will determine the lipid electrophile species and pathways of formation in S. aureus. This aim will test the hypothesis that oxidants derived from S. aureus respiration initiate lipid peroxidation resulting in a diverse array of bactericidal lipid electrophiles. In Aim 2, we will discover the protein targets of AA-derived lipid electrophiles in S. aureus. This aim will test the hypothesis that lipid electrophiles exert toxicity by disrupting enzymes in essential S. aureus processes through post-translational modification. In Aim 3, we will define the role of AA release in S. aureus pathogenesis. This aim will test the hypothesis that inhibiting host AA release results in increased S. aureus pathogenesis in a murine model of systemic infection and that the bactericidal role of AA will be different across the multiple host tissues tested. The insights gained from this proposal will further validate lipid peroxidation as an antimicrobial therapy, identify S. aureus proteins to target for antimicrobial development, and expand the understanding of the bactericidal role of AA in vivo.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = -$917 )
2025	2023	LOUISIANA STATE UNIVERSITY	202 HIMES HALL	BATON ROUGE	LA	70803	EAST BATON ROUGE	USA	Allergy and Infectious Diseases Research	000	2	2/18/2025	NON-COMPETING CONTINUATION	-$917
														Subtotal = -$917

Issue Date FY: 2023 ( Subtotal = $107,265 )
2023	2023	LOUISIANA STATE UNIVERSITY	202 HIMES HALL	BATON ROUGE	LA	70803	EAST BATON ROUGE	USA	Allergy and Infectious Diseases Research	000	2	8/1/2023	NON-COMPETING CONTINUATION	$107,265
														Subtotal = $107,265

Issue Date FY: 2022 ( Subtotal = $161,265 )
2022	2022	LOUISIANA STATE UNIVERSITY	202 HIMES HALL	BATON ROUGE	LA	70803	EAST BATON ROUGE	USA	Allergy and Infectious Diseases Research	000	1	9/12/2022	NEW	$161,265
														Subtotal = $161,265

Grand Total All Awards = $267,613

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Defining the mechanism of lipid peroxidation in controlling Staphylococcus aureus infections

Award Number: K22AI153677

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 09/12/2022

PERIOD OF PERFORMANCE END DATE: 08/31/2024

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer